86 related articles for article (PubMed ID: 32710877)
1. Assessing the diagnostic value of Xpert HPV - Authors' reply.
Kuhn L; Saidu R; Denny L
Lancet Glob Health; 2020 Aug; 8(8):e998. PubMed ID: 32710877
[No Abstract] [Full Text] [Related]
2. Assessing the diagnostic value of Xpert HPV.
Sabour S
Lancet Glob Health; 2020 Aug; 8(8):e997. PubMed ID: 32710876
[No Abstract] [Full Text] [Related]
3. Authors' reply re: Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.
de Kok IM; van Rosmalen J; van Ballegooijen M
BJOG; 2016 Jul; 123(8):1401-2. PubMed ID: 27272299
[No Abstract] [Full Text] [Related]
4. Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Akbari A; Vanden Broeck D; Benoy I; Padalko E; Bogers J; Arbyn M
Virol J; 2018 Oct; 15(1):166. PubMed ID: 30373616
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic methods and techniques in cervical cancer prevention Part II: Molecular diagnostics of HPV infection.
Vince A; Lepej SZ
Med Glas (Zenica); 2010 Feb; 7(1):18-25. PubMed ID: 20387720
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of human papillomavirus genotyping.
Choi YJ; Park JS
J Gynecol Oncol; 2016 Mar; 27(2):e21. PubMed ID: 26768784
[TBL] [Abstract][Full Text] [Related]
8. HPV prevalence in women attending cervical screening in rural Malawi using the cartridge-based Xpert
Cubie HA; Morton D; Kawonga E; Mautanga M; Mwenitete I; Teakle N; Ngwira B; Walker H; Walker G; Kafwafwa S; Kabota B; Ter Haar R; Campbell C
J Clin Virol; 2017 Feb; 87():1-4. PubMed ID: 27984765
[TBL] [Abstract][Full Text] [Related]
9. [Screening of cervical cancer and test for HPV].
Hirai Y
Gan To Kagaku Ryoho; 2010 Feb; 37(2):232-5. PubMed ID: 20235390
[No Abstract] [Full Text] [Related]
10. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
11. Introduction of human papillomavirus DNA screening in the world: 15 years of experience.
Castle PE; de Sanjosé S; Qiao YL; Belinson JL; Lazcano-Ponce E; Kinney W
Vaccine; 2012 Nov; 30 Suppl 5():F117-22. PubMed ID: 23199954
[TBL] [Abstract][Full Text] [Related]
12. Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women.
Mbulawa ZZA; Wilkin TJ; Goeieman B; Swarts A; Williams S; Levin S; Faesen M; Smith JS; Chibwesha CJ; Williamson AL; Firnhaber C
Papillomavirus Res; 2016 Dec; 2():56-60. PubMed ID: 29074186
[TBL] [Abstract][Full Text] [Related]
13. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
Castle PE; Eaton B; Reid J; Getman D; Dockter J
J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
[TBL] [Abstract][Full Text] [Related]
14. Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas.
Vaughan LM; Malinowski DP
Rev Bras Ginecol Obstet; 2019 May; 41(5):357-359. PubMed ID: 31181587
[No Abstract] [Full Text] [Related]
15. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
Toliman P; Badman SG; Gabuzzi J; Silim S; Forereme L; Kumbia A; Kombuk B; Kombati Z; Allan J; Munnull G; Ryan C; Vallely LM; Kelly-Hanku A; Wand H; Mola GDL; Guy R; Siba P; Kaldor JM; Tabrizi SN; Vallely AJ
J Clin Microbiol; 2016 Jul; 54(7):1734-1737. PubMed ID: 27076663
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
Surriabre P; Torrico A; Vargas T; Ugarte F; Rodriguez P; Fontaine V
BMC Infect Dis; 2019 Oct; 19(1):842. PubMed ID: 31615443
[TBL] [Abstract][Full Text] [Related]
17. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
18. [Cervical cancer screning: from cytology to HPV testing].
Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
[TBL] [Abstract][Full Text] [Related]
19. [Cervical cancer--possibilities of detection of human papillomavirus].
Ondryášová H; Koudeláková V; Hajdúch M
Ceska Gynekol; 2013 Jun; 78(3):289-94. PubMed ID: 23869837
[TBL] [Abstract][Full Text] [Related]
20. Patient safety and the next generation of HPV DNA tests.
Lee SH
Am J Clin Pathol; 2011 Mar; 135(3):481; author reply 482-3. PubMed ID: 21350106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
